Effects ofα-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

Lipoic Acid ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12745 ◽

2016 ◽

Vol 18 (12) ◽

pp. 1207-1216 ◽

Cited By ~ 29

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Akira Okitsu ◽

Seitaro Asahina

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

A Double Blind Study of the Effect of Acipimox on Serum Lipids, Blood Glucose Control and Insulin Action in Non-obese Patients with Type 2 Diabetes Mellitus

Diabetic Medicine ◽

10.1111/j.1464-5491.1992.tb01730.x ◽

1992 ◽

Vol 9 (10) ◽

pp. 908-914 ◽

Cited By ~ 28

Author(s):

G.R. Fulcher ◽

C. Catalano ◽

M. Walker ◽

M. Farrer ◽

J. Thow ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Action ◽

Serum Lipids ◽

Blood Glucose Control ◽

Double Blind Study ◽

Obese Patients ◽

Efficacy and safety of teneligliptin in Indian patients with inadequately controlled Type 2 diabetes mellitus: A randomized, double-blind study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/ijem.ijem_97_16 ◽

2018 ◽

Vol 22 (1) ◽

pp. 41 ◽

Cited By ~ 5

Author(s):

Piyush Agarwal ◽

Chhavi Jindal ◽

Vinayak Sapakal

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Indian Patients

A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)

Diabetes Technology & Therapeutics ◽

10.1089/dia.2013.0253 ◽

2014 ◽

Vol 16 (2) ◽

pp. 63-71 ◽

Cited By ~ 49

Author(s):

Rajendrakumar H. Jani ◽

Vikas Pai ◽

Pramod Jha ◽

Gunjan Jariwala ◽

Satinath Mukhopadhyay ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Safety And Efficacy ◽

Atorvastatin Therapy

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01366.x ◽

2011 ◽

Vol 13 (5) ◽

pp. 418-425 ◽

Cited By ~ 63

Author(s):

G. E. Umpierrez ◽

T. Blevins ◽

J. Rosenstock ◽

C. Cheng ◽

J. H. Anderson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Double Blind ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2011.02.010 ◽

2011 ◽

Vol 92 (2) ◽

pp. 253-260 ◽

Cited By ~ 45

Author(s):

Andreia Madruga de Oliveira ◽

Patrícia Helen Carvalho Rondó ◽

Liania Alves Luzia ◽

Francisco Homero D’Abronzo ◽

Vanessa Kristine Illison

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Sensitivity ◽

Lipid Profile ◽

Lipoic Acid ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Sa1928 A 24-WEEK, DOUBLE-BLIND, RANDOMIZED TRIAL OF FECAL MICROBIOTA TRANSPLANTATION ON MICROBIAL ACQUISITION IN OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS

Gastroenterology ◽

10.1016/s0016-5085(20)31886-2 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-483-S-484

Author(s):

Zhilu XU ◽

Keli Yang ◽

Qin Liu ◽

Whitney Tang ◽

Tao Zuo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Trial ◽

Fecal Microbiota Transplantation ◽

Fecal Microbiota ◽

Obese Patients ◽

A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Case Medical Research ◽

10.31525/ct1-nct03969719 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fatty Liver Disease ◽

Double Blind Study ◽

Investigational Product ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study

Diabetology International ◽

10.1007/s13340-018-0359-x ◽

2018 ◽

Vol 10 (1) ◽

pp. 37-50 ◽

Cited By ~ 3

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Seitaro Asahina ◽

Taishi Sakatani

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Double Blind Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Open Label Extension

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

Diabetes Care ◽

10.2337/diacare.21.8.1288 ◽

1998 ◽

Vol 21 (8) ◽

pp. 1288-1294 ◽

Cited By ~ 430

Author(s):

P. A. Hollander ◽

S. C. Elbein ◽

I. B. Hirsch ◽

D. Kelley ◽

J. McGill ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽